SCHEMBL1138366

SCHEMBL1138366

CN(C)CCOc1ccc(BO)c(-c2ccc(Cl)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 4/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
CXCR1 P25024 1/20 0.46
ACHE P22303 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CHRNB2 P17787 2/20 0.43
CHRNA4 P43681 2/20 0.43
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
ESRRG P62508 1/20 0.42
AGER Q15109 1/20 0.40
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27544139 0.77 HRH3 (0.51) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL6598625 0.75 HRH3 (0.69) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL1138527 0.75 KDM4E (0.43) HRH3CYP1A2CYP3A4CYP2C19KDM4E
SCHEMBL1958163 0.74 HRH3 (0.48) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL6599620 0.74 HRH3 (0.67) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL1138538 0.72 ALDH1A1 (0.38) MAPTKDM4EALDH1A1
SCHEMBL7458546 0.69 MAPT (0.50) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL1138367 0.68 HRH3 (0.59) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL5726049 0.68 HRH3 (0.68) HRH3CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL2522577 0.68 HRH3 (0.59) HRH3CYP1A2CYP3A4CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765358-B1 TREATMENT OR PREVENTION OF SKIN CONDITIONS OR TISSUE CONDITIONS IN ANIMALS USING BORYLOXYPYRIDYLMETHANONES ANACOR PHARMACEUTICALS INC (US) 2011-02-23 EP disclosed
EP-1765358-A2 TREATMENT OR PREVENTION OF SKIN CONDITIONS OR TISSUE CONDITIONS IN ANIMALS USING BORYLOXYPYRIDYLMETHANONES Anacor Pharmaceuticals, Inc. (US) 2007-03-28 EP disclosed
WO-2005123094-A2 TREATMENT OR PREVENTION OF SKIN CONDITIONS OR TISSUE CONDITIONS IN ANIMALS USING BORYLOXYPYRIDYLMETHANONES ANACOR PHARMACEUTICALS, INC. (US) 2005-12-29 WO disclosed